TNFAIP2 and acute myeloid leukemia: For example, TXNIP rs7211 was associated with AML sensitivity to cytarabine- and anthracycline-containing induction therapies; TXNIP rs9245 and TNFAIP2 rs1132339 were associated with AML relapse.